SLC19A2 and thiamine-responsive megaloblastic anemia syndrome: <b>Background:</b> Thiamine-responsive megaloblastic anemia syndrome (TRMA) is a rare autosomal recessive hereditary disease due to mutations in <i>SLC19A2</i>.